✦ LIBER ✦

DYSLIPIDEMIA TREATMENT AND HEART FAILURE RISK

✍ Scribed by Velagaleti, Raghava; Sims, Casandra; Gaziano, John

Book ID: 123118341
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 146 KB
Volume: 61
Category: Article
ISSN: 1558-3597
DOI: 10.1016/S0735-1097(13)61435-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Hyperkalemia Risk and Treatment of Heart

Hyperkalemia Risk and Treatment of Heart Failure

✍ Segura, Julian; Ruilope, Luis M. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 414 KB

Metabolic Syndrome and Heart Failure—The

Metabolic Syndrome and Heart Failure—The Risk, Paradox, and Treatment

✍ Krishna K. Gaddam; Hector O. Ventura; Carl J. Lavie 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 195 KB

Atrial Fibrillation and Congestive Heart

Atrial Fibrillation and Congestive Heart Failure: Risk Factors, Mechanisms, and Treatment

✍ E. Kevin Heist; Jeremy N. Ruskin 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 604 KB

Heart Failure Treatments

✍ Dr Johannes Feenstra, Jacobus Lubsen, Diederick E. Grobbee, Bruno H. Ch Stricker 📂 Article 📅 1999 🏛 Springer International Publishing AG 🌐 English ⚖ 127 KB

INFLUENCES OF DYSLIPIDEMIA ON CLINICAL C

INFLUENCES OF DYSLIPIDEMIA ON CLINICAL CHARACTERISTICS IN HEART FAILURE PATIENTS

✍ Hsu, C.H.; Li, W.T.; Wu, C.L.; Chen, P.S.; Tsai, W.C.; Chen, C.W.; Liu, Y.W.; Li 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 71 KB

Heart failure: Pathophysiology and treat

Heart failure: Pathophysiology and treatment

✍ Eugene Braunwald 📂 Article 📅 1981 🏛 Elsevier Science 🌐 English ⚖ 551 KB